New perspectives for brain therapeutics
Funded by IMI, IM2PACT tackles the unmet challenge of discovery and characterization of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative and metabolic diseases. Artemis is in charge of understanding the mechanisms of transcytosis and translating this knowledge into the development of nanoparticles that exploit this mechanism to enter the brain.
